Recipharm is involved in a collaboration with the kingdom of Morocco to construct the largest fill and finish platform in Africa. The SENSYO Pharmatech facility will manufacture vaccines and biotherapeutics – to promote vaccine independence in Morocco and supply other African countries with affordable vaccines. The facility will position Morocco as a key biotechnology hub by integrating research, clinical development, manufacturing and the marketing of pharmaceutical products.
Drive towards African vaccine sovereignty
The facility will focus on the fill and finish of vaccines and will feature three industrial lines that are forecast to produce more than 100 million doses in 2024. These lines will be dedicated to producing vials and vaccines in syringes. SENSYO is being constructed on a 30-hectare greenfield site and is expected to be operational by 2023. “We are proud to be involved as the CDMO of choice in this fantastic step forward for Morocco and Africa,” said Marc Funk, CEO of Recipharm, “Breaking ground on a facility of this magnitude is a significant milestone and reflects the depth of our joint commitment to meeting Morocco’s long-term healthcare needs.”